FDA Approves Omaveloxolone As First Treatment for Friedreich Ataxia
The FDA has approved omaveloxolone (Skyclarys), an agent developed by Reata Pharmaceuticals for the treatment
Ataxia
The FDA has approved omaveloxolone (Skyclarys), an agent developed by Reata Pharmaceuticals for the treatment